18F-DOPA制备研究进展

6-[^18F]氟-L-多巴(^18F-DOPA)为神经系统疾病和脑部肿瘤的理想示踪剂,广泛用于神经内分泌瘤的显像。本文综述近几年亲电取代法和亲核取代法合成^18F-DOPA取得的新进展,重点介绍新型标记前体和手性相转移催化剂在亲核取代法制备^18F-DOPA中的应用。...

Full description

Saved in:
Bibliographic Details
Published in同位素 Vol. 30; no. 1; pp. 71 - 77
Main Author 贾丽娜 张岚
Format Journal Article
LanguageChinese
Published 中国科学院上海应用物理研究所放射化学与工程技术部,上海201800 2017
中国科学院核辐射与核能技术重点实验室,上海201800
中国科学院钍基熔盐堆核能系统卓越创新中心,上海201800
Subjects
Online AccessGet full text
ISSN1000-7512
DOI10.7538/tws.2017.30.01.0071

Cover

Abstract 6-[^18F]氟-L-多巴(^18F-DOPA)为神经系统疾病和脑部肿瘤的理想示踪剂,广泛用于神经内分泌瘤的显像。本文综述近几年亲电取代法和亲核取代法合成^18F-DOPA取得的新进展,重点介绍新型标记前体和手性相转移催化剂在亲核取代法制备^18F-DOPA中的应用。
AbstractList TL92+3%R817.9; 6-[18F]氟-L-多巴(18F-DOPA)为神经系统疾病和脑部肿瘤的理想示踪剂,广泛用于神经内分泌瘤的显像.本文综述近几年亲电取代法和亲核取代法合成18 F-DOPA取得的新进展,重点介绍新型标记前体和手性相转移催化剂在亲核取代法制备18F-DOPA中的应用.
6-[^18F]氟-L-多巴(^18F-DOPA)为神经系统疾病和脑部肿瘤的理想示踪剂,广泛用于神经内分泌瘤的显像。本文综述近几年亲电取代法和亲核取代法合成^18F-DOPA取得的新进展,重点介绍新型标记前体和手性相转移催化剂在亲核取代法制备^18F-DOPA中的应用。
Abstract_FL [18F]6-fluoro-3,4-dihydroxy-L-phenylalanine (18 F-DOPA) has been known to be a useful radiotracer for neuropsychiatric diseases and brain malignancies,and it is also abundantly used for visualizing neuroendocrine tumors at present.However,its more widespread clinical use was hampered by the lack of a high specific activity,high yielding labeling method.This review mainly summarized new developments in the synthesis of 18 F-DOPA with electrophilic reactions and nucleophilic substitution reactions in recent years.Among these,considerable advances in nucleophilic synthesis had been achieved by developing novel precursors and utilizing chiral phase-transfer catalysts (cPTC) mediated fluorinations allowing for the production of 18F-DOPA in high specific activity and high radiochemical yield.
Author 贾丽娜 张岚
AuthorAffiliation 中国科学院上海应用物理研究所放射化学与工程技术部,上海201800 中国科学院钍基熔盐堆核能系统卓越创新中心,上海201800 中国科学院核辐射与核能技术重点实验室,上海201800
AuthorAffiliation_xml – name: 中国科学院上海应用物理研究所放射化学与工程技术部,上海201800;中国科学院钍基熔盐堆核能系统卓越创新中心,上海201800;中国科学院核辐射与核能技术重点实验室,上海201800
Author_xml – sequence: 1
  fullname: 贾丽娜 张岚
BookMark eNotjztOw0AURacIEiFkA9AhWpv35u8yCgSQIoUivTUfOxjBGGxQxApgAVDRUNBQ0qRlNVZYBoNCdZuje8_dIb1Qh4KQfYRUCaaP7pdtSgFVyiAFTAEU9kgfASBRAuk2GbZtZYFLSQVkuk_2UE-S49nFqHtedR9P6_eX9efq5_ut-3rdJVuluW6L4X8OyHxyMh-fJdPZ6fl4NE2ckJgUtvQ282idpmhBF5JbjZmRSilKtRbKWM48B6qNpJ67wjnlpaNRIUp4NiCHm9qlCaUJi_yqfmhCHMzjmb8vgIAYsYMN5i7rsLirInjbVDemecylQs4oZMB-Adq_TxA
ClassificationCodes TL92+3%R817.9
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W92
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.7538/tws.2017.30.01.0071
DatabaseName 中文科技期刊数据库
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-工程技术
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
DocumentTitleAlternate Research Progress in the Preparation of ^18F-DOPA
DocumentTitle_FL Research Progress in the Preparation of 18F-DOPA
EndPage 77
ExternalDocumentID tws201701011
671432090
GrantInformation_xml – fundername: 国家自然科学基金
  funderid: (11505269)
GroupedDBID -02
-05
2B.
2C0
2C~
2RA
5VS
5XA
5XD
5XF
92H
92I
92L
ACGFS
ALMA_UNASSIGNED_HOLDINGS
ARCSS
CCEZO
CEKLB
CIEJG
CQIGP
CW9
GROUPED_DOAJ
IPNFZ
KQ8
RIG
TCJ
TGT
U1G
U5M
W92
~WA
4A8
93N
ABJNI
PSX
ID FETCH-LOGICAL-c561-ebfdb9d1bc821b08e64b819a6777228857ab43d4028a62d4cecc7d6c2662625d3
ISSN 1000-7512
IngestDate Thu May 29 04:03:57 EDT 2025
Wed Feb 14 10:05:26 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords 亲核取代
新型标记前体
nucleophilic substitution
手性相转移催化剂
chiral phase transfer catalyst
new precursor
18F-DOPA
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c561-ebfdb9d1bc821b08e64b819a6777228857ab43d4028a62d4cecc7d6c2662625d3
Notes 11-2566/TL
18F-DOPA; nucleophilic substitution; new precursor; chiral phase transfer catalyst
[^18F]6-fluoro-3,4-dihydroxy-L-phenylalanine(^18F-DOPA)has been known to be a useful radiotracer for neuropsychiatric diseases and brain malignancies,and it is also abundantly used for visualizing neuroendocrine tumors at present.However,its more widespread clinical use was hampered by the lack of a high specific activity,high yielding labeling method.This review mainly summarized new developments in the synthesis of ^18F-DOPA with electrophilic reactions and nucleophilic substitution reactions in recent years.Among these,considerable advances in nucleophilic synthesis had been achieved by developing novel precursors and utilizing chiral phase-transfer catalysts(cPTC)mediated fluorinations allowing for the production of ^18F-DOPA in high specific activity and high radiochemical yield.
JIA Li-na1,2,3,ZHANG Lan1,2,3 (1.Department of Radiochemistry and Engineering, Shanghai Institute of Applied Physics, Chinese Academy of
PageCount 7
ParticipantIDs wanfang_journals_tws201701011
chongqing_primary_671432090
PublicationCentury 2000
PublicationDate 2017
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017
PublicationDecade 2010
PublicationTitle 同位素
PublicationTitleAlternate Isotopes
PublicationTitle_FL Journal of Isotopes
PublicationYear 2017
Publisher 中国科学院上海应用物理研究所放射化学与工程技术部,上海201800
中国科学院核辐射与核能技术重点实验室,上海201800
中国科学院钍基熔盐堆核能系统卓越创新中心,上海201800
Publisher_xml – name: 中国科学院钍基熔盐堆核能系统卓越创新中心,上海201800
– name: 中国科学院上海应用物理研究所放射化学与工程技术部,上海201800
– name: 中国科学院核辐射与核能技术重点实验室,上海201800
SSID ssib046625098
ssj0039471
ssib051370769
ssib000862156
ssib038074670
Score 2.0890443
Snippet 6-[^18F]氟-L-多巴(^18F-DOPA)为神经系统疾病和脑部肿瘤的理想示踪剂,广泛用于神经内分泌瘤的显像。本文综述近几年亲电取代法和亲核取代法合成^18F-DOPA取得的新进展,重...
TL92+3%R817.9; 6-[18F]氟-L-多巴(18F-DOPA)为神经系统疾病和脑部肿瘤的理想示踪剂,广泛用于神经内分泌瘤的显像.本文综述近几年亲电取代法和亲核取代法合成18 F-DOPA取得...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 71
SubjectTerms 18F-DOPA
亲核取代
手性相转移催化剂
新型标记前体
Title 18F-DOPA制备研究进展
URI http://lib.cqvip.com/qk/96299X/201701/671432090.html
https://d.wanfangdata.com.cn/periodical/tws201701011
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  issn: 1000-7512
  databaseCode: KQ8
  dateStart: 19880101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  omitProxy: true
  ssIdentifier: ssj0039471
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  issn: 1000-7512
  databaseCode: DOA
  dateStart: 20060101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://www.doaj.org/
  omitProxy: true
  ssIdentifier: ssj0039471
  providerName: Directory of Open Access Journals
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKOcCl4ina0qoHfExJHMePY5LdVQUSD6lIva3yanvaFtgKqX8AfgCcuHDgwpFLr_yaVfkZfGMn25SuxEMrWZY9Gc9k1vY3VjzD2KOiElIDFgc6aopA6qoMShlXmFeiVMZKUZXuK99naueVfLKX7C1dW-l9tXQyLber04X3Sv7HqmiDXemW7D9Yds4UDajDvihhYZR_ZePIjILB8xcpHybcGJ4pqqRAh5oPNU9DbqWrWNcFghG3GdFkEfdJJztcSo025CbnQ8mzATcDejCTYNKZxDFA59CRGKKi0Qy3-QUJWOc0MFUEt2n_UMHfnnR_gJZF6lhApMwNl2puI8d0wFMIbLm1PBUtsYGaimdgrB37tNUOJYRAxVjSlFqgiFr0BhTRmJAq1msCPiCW7gXm3Kre6H5QTwMOieODlszxSTs-UHdEopqYekV-VVpB0cvC3upP1-x1El3aHuLwyjTwa71PHdOiBp-L5vf9CL4g3bGYvqPA8JHejkMXIzbsHr0U6BtURERB_-DOXxeYQrTTPH3Zx8sKEG2OHylZADa6-YIrFbzZ8MJ_TqJYh5oyyHtoEtv2BKLT04fhIikfL5CRwo0cHk0OXgNEuTttk_1ictCDX7u32ErrN22lfhLcZkunh3fYjbxLV3iXrXWTYfbhbPb1_fmXj-ffzn7--Dz7_uke2x0Nd_OdoE38EVSA80FT7telraOyMiIqQ9MoWQK4FkrDFRTGJLrAelJLQONCiVpWWIZ0rSpgTYEXUMf32fLkaNI8YFtS2ypumpgOBrA7xaVVDX6VKApVNkm9ytbnKo6PfXyXsdJwIkRow1W20So9bmf923HfSmt_6F9nN6nuT-wesuXpm5NmAxh2Wm66s59NZ91fpy1lNA
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=18F-DOPA%E5%88%B6%E5%A4%87%E7%A0%94%E7%A9%B6%E8%BF%9B%E5%B1%95&rft.jtitle=%E5%90%8C%E4%BD%8D%E7%B4%A0&rft.au=%E8%B4%BE%E4%B8%BD%E5%A8%9C&rft.au=%E5%BC%A0%E5%B2%9A&rft.date=2017&rft.pub=%E4%B8%AD%E5%9B%BD%E7%A7%91%E5%AD%A6%E9%99%A2%E4%B8%8A%E6%B5%B7%E5%BA%94%E7%94%A8%E7%89%A9%E7%90%86%E7%A0%94%E7%A9%B6%E6%89%80%E6%94%BE%E5%B0%84%E5%8C%96%E5%AD%A6%E4%B8%8E%E5%B7%A5%E7%A8%8B%E6%8A%80%E6%9C%AF%E9%83%A8%2C%E4%B8%8A%E6%B5%B7201800&rft.issn=1000-7512&rft.volume=30&rft.issue=1&rft.spage=71&rft.epage=77&rft_id=info:doi/10.7538%2Ftws.2017.30.01.0071&rft.externalDocID=tws201701011
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F96299X%2F96299X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftws%2Ftws.jpg